With Barack Obama’s victory Tuesday night, pharmaceutical companies and advertising groups fear there may be more restrictions placed on their direct-to-consumer advertising once the senator takes office in January, Advertising Age reports. Given Obama’s campaign promise to reform healthcare, changes expected by the advertising and pharmaceutical industries include restricted advertising of certain kinds of drugs, moratoriums on the advertising of new drugs and requiring the Food & Drug Administration to review ads more stringently, AdAge says.
—Christopher Perez